Bioinformatics Advance Access published online on August 2, 2005
Bioinformatics, doi:10.1093/bioinformatics/bti607
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Evolution Group at the Zoology Department, University of Oxford, UK
* To whom correspondence should be addressed.
Motivation: Genetic analysis of HIV-1 is important not only for vaccine development, but also to guide treatment strategies, track the emergence of new viral variants and ensure that diagnostic assays are contemporary and fully optimized. However, most genotyping methods are laborious and complex, and involve the use of multiple software applications. Here, we describe the development of an automated genotyping system that can be easily applied to HIV-1, and other rapidly evolving viral pathogens. Design and Results: The new REGA subtyping tool, developed using Java programming and PERL scripts, combines phylogenetic analyses with bootscanning methods for the genetic subtyping of full-length and subgenomic fragments of HIV-1. When used to investigate the subtype of previously published reference datasets that were analysed using manual phylogenetic methods, the automated method correctly identified 97.5%-100% of non-recombinant and circulating recombinant forms (CRFs) of HIV-1, including 108 full-length, 108 gag and 221 env sequences downloaded from the Los Alamos database. Availability: The tool, which can be easily downloaded and installed on either a UNIX or Linux-based computer system, is available at http//www.bioafrica.net/subtypetool/.
Received March 28, 2005
Revised June 23, 2005
Accepted July 28, 2005
Applications note
An automated genotyping system for analysis of HIV-1 and other microbial sequences
2 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
3 HIV-1 Immunopathogenesis and Therapeutics Research Program, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
4 Department of Infectious Disease Epidemiology, HIV-Laboratory, National Public Health Institute, Helsinki, Finland
5 Research Information Systems Division, South African Medical Research Council, Cape Town, South Africa
6 Eijkman Winkler Institute, Department of Medical Microbiology, Sub department of Virology, University Medical Center Utrecht, Utrecht, the Netherlands; Division of Internal Medicine and Dermatology, Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands
7 Eijkman Winkler Institute, Department of Medical Microbiology, Sub department of Virology, University Medical Center Utrecht, Utrecht, the Netherlands
8 Virology Laboratory, Hospital Egas Moniz, Lisbon, Portugal
Tulio de Oliveira, E-mail: tulio.deoliveira{at}zoo.oxford.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Covens, N. Dekeersmaeker, Y. Schrooten, J. Weber, D. Schols, M. E. Quinones-Mateu, A.-M. Vandamme, and K. Van Laethem Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs J. Clin. Microbiol., July 1, 2009; 47(7): 2232 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Schultz, M. Zhang, I. Bulla, T. Leitner, B. Korber, B. Morgenstern, and M. Stanke jpHMM: Improving the reliability of recombination prediction in HIV-1 Nucleic Acids Res., July 1, 2009; 37(suppl_2): W647 - W651. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. J. Alcantara, S. Cassol, P. Libin, K. Deforche, O. G. Pybus, M. Van Ranst, B. Galvao-Castro, A.-M. Vandamme, and T. de Oliveira A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences Nucleic Acids Res., July 1, 2009; 37(suppl_2): W634 - W642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hue, R. J. Gifford, D. Dunn, E. Fernhill, D. Pillay, and on Behalf of the UK Collaborative Group on HIV Dru Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naive Individuals J. Virol., March 15, 2009; 83(6): 2645 - 2654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Waleria-Aleixo, A. N. Martins, M. B. Arruda, R. M. Brindeiro, R. M. Da-Silva, F. F. Nobre, D. B. Greco, and A. Tanuri Drug Resistance Mutation Profile and Accumulation Kinetics in Human Immunodeficiency Virus-Positive Individuals Infected with Subtypes B and F Failing Highly Active Antiretroviral Therapy Are Influenced by Different Viral Codon Usage Patterns Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4497 - 4502. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hraber, C. Kuiken, M. Waugh, S. Geer, W. J. Bruno, and T. Leitner Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching index J. Gen. Virol., September 1, 2008; 89(9): 2098 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Deforche, R. Camacho, K. Van Laethem, P. Lemey, A. Rambaut, Y. Moreau, and A.-M. Vandamme Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment Bioinformatics, January 1, 2008; 24(1): 34 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gifford, T. de Oliveira, A. Rambaut, O. G. Pybus, D. Dunn, A.-M. Vandamme, P. Kellam, D. Pillay, and on Behalf of the UK Collaborative Group on HIV Dru Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of Human Immunodeficiency Virus Type 1 J. Virol., December 1, 2007; 81(23): 13050 - 13056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. P. Gilbert, A. Rambaut, G. Wlasiuk, T. J. Spira, A. E. Pitchenik, and M. Worobey From the Cover: The emergence of HIV/AIDS in the Americas and beyond PNAS, November 20, 2007; 104(47): 18566 - 18570. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Abecasis, P. Lemey, N. Vidal, T. de Oliveira, M. Peeters, R. Camacho, B. Shapiro, A. Rambaut, and A.-M. Vandamme Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form J. Virol., August 15, 2007; 81(16): 8543 - 8551. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, Z. Cai, X.-F. Wan, T. Hoang, R. Goebel, and G. Lin Nucleotide composition string selection in HIV-1 subtyping using whole genomes Bioinformatics, July 15, 2007; 23(14): 1744 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, C. Li, Y. Fu, F. Gao, O. G. Pybus, K. Abe, H. Okamoto, C. H. Hagedorn, and D. Murphy Complete genomes of hepatitis C virus (HCV) subtypes 6c, 6l, 6o, 6p and 6q: completion of a full panel of genomes for HCV genotype 6 J. Gen. Virol., May 1, 2007; 88(5): 1519 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rousseau, G. H. Learn, T. Bhattacharya, D. C. Nickle, D. Heckerman, S. Chetty, C. Brander, P. J. R. Goulder, B. D. Walker, P. Kiepiela, et al. Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections J. Virol., May 1, 2007; 81(9): 4492 - 4500. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Deforche, T. Silander, R. Camacho, Z . Grossman, M. A. Soares, K. Van Laethem, R. Kantor, Y. Moreau, A.-M. Vandamme, and on behalf of the non-B Workgroup Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance Bioinformatics, December 15, 2006; 22(24): 2975 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Snoeck, R. Kantor, R. W. Shafer, K. Van Laethem, K. Deforche, A. P. Carvalho, B. Wynhoven, M. A. Soares, P. Cane, J. Clarke, et al. Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent Antimicrob. Agents Chemother., February 1, 2006; 50(2): 694 - 701. [Abstract] [Full Text] [PDF] |
||||






